| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,660 | $90 | $152.4K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 310 | $330 | $104.9K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 750 | $110 | $84.6K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 970 | $60 | $59.4K |
| 93229 | In this procedure, the provider, typically a technician, places a wearable electrocardiographic monitoring device on the patient, instructs him in its use, and monitors the transmissions, to detect… | 90 | $640 | $55.8K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 630 | $80 | $47.7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 340 | $130 | $44.5K |
| J2785 | Injection, regadenoson, 0.1 mg | 890 | $40 | $37.5K |
| 99457 | The provider manages treatment using data from remote physiologic monitoring. The service requires at least one real–time interactive communication with the patient or caregiver during the month and… | 980 | $40 | $36.3K |
| 99454 | The provider supplies one or more devices for remote physiologic monitoring that occurs for 16 to 30 days in a 30–day period. | 970 | $40 | $35.7K |